Equillium (EQ) Institutional Ownership $1.87 -0.12 (-6.03%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$1.88 +0.00 (+0.27%) As of 09/12/2025 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Equillium (NASDAQ:EQ)CurrentInstitutional OwnershipPercentage27.05%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$1.39MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$44.72K Get EQ Insider Trade Alerts Want to know when executives and insiders are buying or selling Equillium stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data EQ Institutional Buying and Selling by Quarter Equillium Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2025Renaissance Technologies LLC261,400$196K0.0%-18.6%0.738% 2/12/2025Takeda Pharmaceutical Co. Ltd.1,824,977$1.37M5.2%N/A5.151% 2/11/2025DCF Advisers LLC62,947$47K0.0%+91.0%0.178% 8/9/2024Renaissance Technologies LLC300,400$208K0.0%+43.6%0.852% 5/10/2024Acadian Asset Management LLC108,691$249K0.0%N/A0.308% 2/12/2024Decheng Capital LLC4,447,308$3.22M0.9%N/A12.663% 8/9/2023DCF Advisers LLC111,623$84K0.0%-28.9%0.324% 5/2/2023Victory Capital Management Inc.345,861$252K0.0%-89.2%1.005% 2/14/2023True North Advisors LLC265,370$265K0.1%+50.5%0.771% 2/13/2023Callan Capital LLC103,688$110K0.0%N/A0.301% Get the Latest News and Ratings for EQ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Equillium and its competitors with MarketBeat's FREE daily newsletter. 2/9/2023Victory Capital Management Inc.3,198,745$3.52M0.0%-12.4%9.296% 1/24/2023Capital CS Group LLC24,000$25K0.0%N/A0.070% 11/7/2022Virtu Financial LLC24,141$54K0.0%N/A0.070% 11/2/2022Victory Capital Management Inc.3,651,084$8.11M0.0%+2.1%10.651% 8/11/2022DCF Advisers LLC114,027$233K0.1%-31.2%0.333% 8/1/2022Victory Capital Management Inc.3,577,211$7.30M0.0%-0.6%10.436% 5/16/2022Cota Capital Management LLC562,278$1.77M0.4%N/A1.640% 5/10/2022Decheng Capital Management III Cayman LLC4,447,308$14.01M4.3%N/A12.975% 5/4/2022Victory Capital Management Inc.3,597,799$11.33M0.0%+8.2%10.495% 2/15/2022Samsara BioCapital LLC615,541$2.32M0.5%-16.6%2.094% 2/7/2022Victory Capital Management Inc.3,325,050$12.47M0.0%+4.9%11.313% 11/16/2021Two Sigma Securities LLC83,948$573K0.0%N/A0.286% 11/12/2021Geode Capital Management LLC154,185$1.05M0.0%+2.4%0.525% 11/2/2021Victory Capital Management Inc.3,170,199$21.62M0.0%+9.4%10.789% 8/17/2021Samsara BioCapital LLC738,176$4.35M0.5%-3.4%2.512% 8/17/2021Bridgeway Capital Management LLC141,200$832K0.0%+38.4%0.481% 8/16/2021State Street Corp30,756$181K0.0%N/A0.105% 8/16/2021Goldman Sachs Group Inc.218,162$1.29M0.0%N/A0.742% 8/13/2021DCF Advisers LLC77,538$457K0.2%N/A0.267% 8/13/2021Geode Capital Management LLC150,582$886K0.0%+16.7%0.519% 8/13/2021Vanguard Group Inc.840,545$4.95M0.0%+31.4%2.894% 8/11/2021Deutsche Bank AG356,461$2.10M0.0%+1.8%1.227% (Data available from 1/1/2016 forward) EQ Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of EQ shares? During the previous two years, the following institutional investors and hedge funds held shares of Equillium shares: Decheng Capital LLC ($3.22M), Takeda Pharmaceutical Co. Ltd. ($1.37M), Acadian Asset Management LLC ($249K), and Renaissance Technologies LLC ($196K), DCF Advisers LLC ($47K).Learn more on Equillium's institutional investors. What percentage of Equillium's stock is owned by institutional investors? 27.05% of Equillium's stock is owned by institutional investors. Learn more on EQ's institutional investor holdings. Which institutional investors have been buying Equillium's stock? The following institutional investors have purchased Equillium's stock in the last 24 months: Decheng Capital LLC ($4.45M), Takeda Pharmaceutical Co. Ltd. ($1.82M), Acadian Asset Management LLC ($108.69K), Renaissance Technologies LLC ($91.20K), and DCF Advisers LLC ($29.99K). How much institutional buying is happening at Equillium? Institutional investors have bought a total of 1,854,962 shares in the last 24 months. This purchase volume represents approximately $1.39M in transactions. Which of Equillium's major shareholders have been selling company stock? The following institutional investors have sold Equillium stock in the last 24 months: Renaissance Technologies LLC ($59.77K). How much institutional selling is happening at Equillium? Institutional investors have sold a total of 59,773 shares in the last 24 months. This volume of shares sold represents approximately $44.72K in transactions. Related Companies PureTech Health Institutional Ownership Inhibrx Biosciences Institutional Ownership Autolus Therapeutics Institutional Ownership Kamada Institutional Ownership Aura Biosciences Institutional Ownership Y-mAbs Therapeutics Institutional Ownership Vigil Neuroscience Institutional Ownership Aquestive Therapeutics Institutional Ownership Olema Pharmaceuticals Institutional Ownership Rocket Pharmaceuticals Institutional Ownership This page (NASDAQ:EQ) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump’s right about Epstein.A crisis that could devastate your wealth, upend the dollar, and accelerate the collapse of America’s economy....Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredThe Obscure Korean War Act That Created a $5.39 Billion Passive Income StreamAn obscure Korean War law has just been enacted by the U.S. government... Allowing it to take a heavy hand ...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Equillium, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Equillium With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
